Skip to main content

Table 1 Laboratory and Echocardiographic findings among CSF and NECA groups (values ± SD)

From: Echocardiographic and laboratory findings in coronary slow flow phenomenon: cross-sectional study and review

Variable

CSF (study group)

NECA (control group)

P-value

Laboratory

    

 WBC

 × 103/ml3

7.13 ± 0.87

7.16 ± 1

0.23

 Neutrophil

 × 103/ml3

4.03 ± 0.80

4.80 ± 0.92

0.001

 Lymphocyte

 × 103/ml3

1.95 ± 0.52

1.30 ± 0.12

< 0.001

 N/L Ratio*

–

2.36 ± 1.74

3.70 ± 0.73

0.90

 Hemoglobin

gr/dL

15.39 ± 1.29

13.10 ± 1.14

0.121

 Hematocrit

%

45.25 ± 3.62

38.77 ± 2.19

< 0.001

 Platelet

 × 104/ml3

23.34 ± 3.82

17.46 ± 1.36

< 0.001

 MPV

fL

13.10 ± 1.72

9.90 ± 1.10

0.011

 RDW

%

13.21 ± 1.76

9.55 ± 1.06

0.037

 Creatinine

mg/dL

1.17 ± 0.23

1.07 ± 0.14

0.016

 BUN

mg/dL

16.09 ± 2.49

14.75 ± 1.77

0.144

 FBS

mg/dL

108.60 ± 11.21

90.08 ± 9.45

0.143

 Triglyceride

mg/dL

202.80 ± 48.51

131.84 ± 34.22

0.001

 Total cholesterol

mg/dL

221.50 ± 49.89

144.37 ± 33.21

0.001

 LDL

mg/dL

151.48 ± 34.28

103.34 ± 21.70

< 0.001

 HDL

mg/dL

46.56 ± 6.56

52.91 ± 6.21

0.756

Echocardiography

    

 LVEF

%

54.52 ± 1.47

54.78 ± 1.01

0.020

 IVSD

cm

1.02 ± 0.10

1.03 ± 0.08

0.049

 LVEDD

cm

4.96 ± 0.14

5.00 ± 0.21

0.201

 LVESD

cm

2.66 ± 0.15

2.68 ± 0.22

0.861

 E wave

ms

0.63 ± 0.17

0.75 ± 0.14

0.029

 A wave

ms

0.75 ± 0.12

0.73 ± 0.11

0.546

 E/A ratio

–

0.85 ± 0.24

1.03 ± 0.20

0.733

 DT

ms

179.94 ± 7.61

180.44 ± 5.54

0.093

 LV systolic GLS

–

− 15.86 ± 0.91

− 18.59 ± 0.59

0.010

  1. The bold values in P-value column, are significant as p-value < 0.05
  2. *Neutrophil/Lymphocyte Ratio